Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Sep;561(7723):E17-E19.
doi: 10.1038/s41586-018-0494-3. Epub 2018 Sep 19.

The role of CD32 during HIV-1 infection

Lynn N Bertagnolli  1 , Jennifer A White  1 , Francesco R Simonetti  1 , Subul A Beg  1   2 , Jun Lai  1   2 , Costin Tomescu  3 , Alexandra J Murray  1 , Annukka A R Antar  1 , Hao Zhang  4 , Joseph B Margolick  4 , Rebecca Hoh  5 , Stephen G Deeks  5 , Pablo Tebas  6 , Luis J Montaner  3 , Robert F Siliciano  7   8 , Gregory M Laird  1 , Janet D Siliciano  1
Affiliations
Comment

The role of CD32 during HIV-1 infection

Lynn N Bertagnolli et al. Nature. 2018 Sep.

Abstract

Persistence of latent HIV-1 in long-lived resting memory CD4+ T cells is a major barrier to curing HIV-1 infection, and thus a biomarker for latently infected cells would be of great scientific and clinical importance.,,,, Through an elegant discovery-based approach, Descours et al. reported that CD32a, an Fcγ receptor not normally expressed on T cells, is a potential biomarker for latently infected cells. Using the quantitative viral outgrowth assay, we show that CD32+ CD4+ T cells do not harbor the majority of intact proviruses in the latent reservoir and that the enrichment found by Descours et al. may in part reflect the use of an ultrasensitive ELISA for HIV-1 p24 antigen that does not predict exponential viral outgrowth. Our studies show that CD32 is not a biomarker for the major population of latently infected CD4+ T cells.

PubMed Disclaimer

Conflict of interest statement

Competing Financial Interests

The authors declare no competing financial interests.

Figures

Fig. 1.
Fig. 1.
A) Percentage of CD4+CD32hi T cells relative to total CD4+ T cells in healthy donors and HIV-1 infected donors. Infected donor values reported by Descours et al. were obtained from Supplementary Table 4 of reference . B) Schematic depicting 3 strategies used to obtain different populations of CD4+ T cells plated in QVOAs. C) Numbers of sorted CD4+CD32hi and CD3+CD4+CD32hi T cells from each subject plated in QVOAs. D) Frequencies of latently infected cells among CD4+CD32hi T cells and CD4+CD32neg T cells and among total CD4+ T cells from the same subjects previously measured in separate experiments. Cells were isolated using protocol 1 (colors coordinate with subject values from Fig 1c). E) Probability of detecting outgrowth based on measured frequencies of latently infected cells among the CD4+CD32neg fraction and number of CD4+CD32hi cells plated assuming various degrees of enrichment of HIV-1 in CD32hi cells. F) Frequencies of latently infected cells measured in QVOAs using positive or negative selection to obtain total CD4+ cells (protocol 2; positive selection was accomplished using either sorting or CD4 microbead strategies, with similar results). G) Comparison of proviral DNA measurements obtained with Qpcr on total CD4+ cells purified using positive or negative selection (protocol 2). H) Frequencies of latently infected cells among total CD4 cells, and CD3+CD4+CD32neg and CD3+CD4+CD32hi populations. Cells were isolated using protocol 3 (colors coordinate with subject values from Fig 1c).
Fig. 2.
Fig. 2.
Ultrasensitive p24 measurements as a possible factor in overestimation of latent infection. A) p24 values from CD32+ culture wells measured with ELISA versus SIMOA (Lower limit of quantification (LLOQ): 5–10 pg/mL and 0.01 pg/mL, respectively) (data collected from three subjects, for a total of 71 wells). B) Longitudinal p24 values measured with SIMOA in individual culture wells in the QVOA for CD32neg cells from subject 5, showing wells with and without viral outgrowth (red and blue circles, respectively). C) p24 values in QVOA wells of CD32hi and CD32neg cultures. Day 21 values are shown for CD32neg culture wells with outgrowth as detected by ELISA (red), CD32neg culture wells with no outgrowth by ELISA but with positive SIMOA values (blue), and CD32hi culture wells with no outgrowth by ELISA but with positive SIMOA values (orange). Date were collected from subjects 2, 4, and 5. p values were calculated with a non-parametric t-test. D) IUPM calculation based on ELISA versus SIMOA. Symbols in dark grey represent values below the limit of detection. E) Fold enrichment of IUPM in CD32+ cells (subject ID shown on the horizontal axis).
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Finzi D et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295–1300 (1997). - PubMed
    1. Chun TW et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U.S.A 94, 13193–13197 (1997). - PMC - PubMed
    1. Wong JK et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291–1295 (1997). - PubMed
    1. Richman DD et al. The challenge of finding a cure for HIV infection. Science 323, 1304–7 (2009) - PubMed
    1. Deeks SG et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 12, 607–14 (2012) - PMC - PubMed

Publication types